cymed
Japanese Med-Tech startup CyMed (株式会社CyMed) builds the 'Efficient Frontier' integrated clinical SaaS platform, DX support services, and an OTC e-commerce channel for Japanese medical institutions and consumers across the healthcare journey.
- Company typePrivate
- Founded2022
- HeadquartersSarasota, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingSoftware
What cymed does
CyMed (株式会社CyMed) is a Japanese Med-Tech startup founded in March 2022 by physician-CEO Ishikawa Hirokazu (previously at Japan M&A Center) and COO Sawada Rin, headquartered in Shibuya, Tokyo. The company targets structural fragmentation in Japanese healthcare through three integrated business lines: (1) the 'Efficient Frontier' integrated medical SaaS platform for hospitals and clinics, (2) DX consulting that includes workflow redesign and staff adoption support beyond software deployment, and (3) a direct-to-consumer e-commerce channel for OTC medicines and self-care products. The three lines are designed to span the healthcare journey from prevention and self-care through clinical treatment and ongoing care.
The Efficient Frontier SaaS consolidates clinical operations, billing, and prescriptions into a unified system intended to replace the fragmented departmental systems common in Japanese medical institutions. The platform is built on a modern cloud stack (TypeScript, Next.js, React, TailwindCSS frontend; Firebase and Google Cloud Platform backend; BigQuery for analytics; GitHub Actions for CI/CD; Sentry for monitoring). Distribution is direct enterprise sales to medical institutions in Japan, currently concentrated in the Kanto region, supported by multi-channel marketing (Google Ads, Meta Ads, TikTok/YouTube, an affiliate program, and a Wantedly presence) that doubles as employer branding.
The business model combines recurring SaaS subscriptions (quote-based, annual billing, tailored to institution size), professional services revenue from DX engagements (workflow redesign, operational improvement, staff adoption), and transaction-based revenue from the OTC e-commerce storefront. The company is privately held with no disclosed institutional funding rounds and operates with a small, founder-led team (only five team members are publicly named, including a PM hire in August 2025 and a system engineer handling both engineering and marketing functions). External recognitions in 2025 — Wantedly Awards 2025 EPISODE CATEGORY GOLD and selection for Best Venture 100 — have been used to support active recruitment.
cymed firmographics
Firmographics- Name
- cymed
- Legal name
- 株式会社CyMed
- Website
- https://cymed.co.jp
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Japanese Med-Tech startup CyMed (株式会社CyMed) builds the 'Efficient Frontier' integrated clinical SaaS platform, DX support services, and an OTC e-commerce channel for Japanese medical institutions and consumers across the healthcare journey.
- Ownership category
- akta.pro rank
cymed industry classification
Industry- Product category
- Healthcare Practice Management Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Virtual Pharmacy & Medication Management Integration Platforms (HLALABAL)
- akta.pro secondary industry
- Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH)
Keywords
Where cymed is headquartered
LocationHeadquarters
- HQ city
- Sarasota
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
cymed business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Marketing or Sales, Technology or R&D, Operations
Revenue model
- SaaS Subscriptions - Efficient Frontier: Recurring subscription revenue from providing integrated medical management SaaS to healthcare institutions. The platform centralizes clinical operations and provides ongoing value through updates and support.
- DX Consulting Services: Professional services revenue from comprehensive digital transformation support, including workflow redesign, operational improvement consulting, and staff training and adoption support.
- OTC Medicines E-commerce: Direct-to-consumer e-commerce sales of over-the-counter medicines and self-care products, supporting the end-to-end healthcare journey.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise SaaS pricing for medical institutions |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels7 records
cymed product offering
Product offeringCore offering
CyMed develops and provides "Efficient Frontier," an integrated cloud-based medical SaaS system that centralizes clinical operations (appointments, patient records, prescriptions, billing) for hospitals and clinics. In parallel, the company offers comprehensive digital transformation (DX) consulting to medical institutions—covering workflow redesign, operations improvement, and staff adoption—and operates an OTC pharmaceutical e-commerce storefront to support end-to-end patient self-care.
Product overview
CyMed offers a single unified product portfolio centered on its core SaaS platform 'Efficient Frontier' — an integrated medical system that consolidates clinical operations. In addition to this primary SaaS offering, CyMed provides DX support services for medical institutions (including business flow redesign, operations improvement, and staff adoption support) and operates an OTC pharmaceutical e-commerce business that promotes self-care. The three service lines are designed to work together to create an end-to-end patient healthcare experience.
Differentiator
Problem solved
Functional benefit
Products and services
- Efficient Frontier (統合医療システム) Integrated cloud-based medical SaaS system that centrally manages clinical operations for hospitals and clinics, eliminating fragmentation between departmental systems and supporting appointments, patient records, prescription management, billing, and payment processing.
- Medical Institution DX Support (医療機関向けDX支援) Comprehensive digital transformation (DX) consulting service for medical institutions, covering workflow redesign, operations improvement, quality management, and staff adoption support to drive organizational change beyond software deployment.
- CyMed OTC Pharmaceutical E-commerce (OTC医薬品EC) Direct-to-consumer online store selling over-the-counter medicines and self-care products, designed to provide an end-to-end patient experience bridging clinical treatment and post-treatment self-care.
Companies that use cymed
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
cymed technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
cymed partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights6 records
cymed competitors and assessment
Company assessmentDirect peers
- Medley: Japanese health-tech company operating CLINICS (cloud-based EMR) and other healthcare SaaS products sold to medical institutions. Most directly comparable to CyMed's Efficient Frontier as a Japanese provider-focused clinical platform.
- EM Systems: Established Japanese vendor of electronic medical records and clinical information systems for clinics and hospitals. Comparable as both a competitor and an incumbent analog to CyMed's integrated clinical operations offering.
- Athenahealth: US-based provider of integrated EHR, practice management, and revenue cycle SaaS for medical groups. Relevant international reference for CyMed's integrated clinical-operations-and-billing SaaS model.
Emerging players
- MICIN: Japanese health-tech firm offering telemedicine and electronic medical record SaaS to medical institutions. Comparable to CyMed as an emerging Japanese clinical-software peer with a similar B2B-institution focus.
- Ubie: Japanese AI-driven symptom-checker and medical-interview SaaS used by clinics and hospitals. Comparable to CyMed as a software-led Japanese health-tech company serving medical institutions with workflow products.
- CureApp: Japanese developer of prescription digital therapeutics and medical software. Comparable to CyMed as a Japanese health-tech company building software-driven clinical products targeting providers and patients.
- Welby: Japanese patient-facing health management SaaS and PHR platform with provider-side integrations. Comparable to CyMed as a Japanese health-tech company spanning clinical and consumer healthcare touchpoints.
Broad incumbents
- M3: Large Japanese healthcare platform operating m3.com and multiple physician- and patient-facing services. Comparable as a broad incumbent serving Japanese medical institutions with technology-enabled offerings.
- Fujitsu (Healthcare): Major Japanese IT conglomerate with an established healthcare division providing EMR and hospital information systems. Represents the entrenched competition CyMed's Efficient Frontier must displace.
- NEC (Healthcare): Major Japanese technology group with healthcare IT solutions including EMR and hospital information systems. Comparable as a large incumbent competing for the same medical-institution software spend.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
cymed social profiles
Digital presencecymed financial estimates
Financial estimateRevenue estimate
Valuation estimate
cymed leadership team
Management profileNumber of profiles
cymed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
cymed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about cymed
What does cymed do?
CyMed develops and provides "Efficient Frontier," an integrated cloud-based medical SaaS system that centralizes clinical operations (appointments, patient records, prescriptions, billing) for hospitals and clinics. In parallel, the company offers comprehensive digital transformation (DX) consulting to medical institutions—covering workflow redesign, operations improvement, and staff adoption—and operates an OTC pharmaceutical e-commerce storefront to support end-to-end patient self-care.
Is cymed a public or private company?
cymed is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was cymed founded?
cymed was founded in 2022. It employs 1 to 10 people.
Where is cymed based?
cymed is headquartered in Sarasota, United States, in the North America region.
How does cymed make money?
Three revenue lines are on record. SaaS Subscriptions - Efficient Frontier is the primary driver. The others are DX Consulting Services and OTC Medicines E-commerce.
Who are cymed's main competitors?
Direct peers on record are Medley, EM Systems and Athenahealth. Emerging players are MICIN, Ubie, CureApp and Welby. Broad incumbents are M3, Fujitsu (Healthcare) and NEC (Healthcare).
Does cymed have an API?
No public API is recorded for cymed.
What industry is cymed in?
cymed's product category is Healthcare Practice Management Software. Its primary akta.pro industry code is HLALABAL, Virtual Pharmacy & Medication Management Integration Platforms, with a secondary code of HLACAKAH, Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools. Its NAICS code is 5132 and its SIC code is 7372.